Skip to main content
. 2017 Aug 22;216(8):1008–1017. doi: 10.1093/infdis/jix421

Figure 1.

Figure 1.

Selection of samples for inclusion in the study. Abbreviations: DP, dihydroartemisinin-piperaquine; DP4w, dihydroartemisinin-piperaquine every 4 weeks; DP8w, dihydroartemisinin-piperaquine every 8 weeks; Pf, Plasmodium falciparum parasitemia; SP, sulfadoxine-pyrimethamine.